NASDAQ · Biotechnology
AMGN
Amgen Inc · $217.90B
403.04
-1.04%
Price
126 sessions shownTechnicals
from daily closesRSI · 14 day
63.0
Avg true range · 14d
2.39%
Volatility · 20d annualised
47.1%
Trend · 20d vs 50d
Down
vs 20-day average
0.96%
vs 50-day average
-1.57%
vs 200-day average
—
200-day average
—
Internals
where it sits, and how hard it is being traded52-week low
283.00
52-week high
447.03
Volume vs its 20-day avg
1.08×
Beta vs the market
0.44
Sitting 73% of the way up its 52-week range (283.00 → 447.03)
Swings
prices it actually turned at — highest or lowest of the surrounding 11 sessionsTurned down · Jul 28
398.00
Turned down · Aug 25
447.03
Turned down · Sep 3
445.82
Turned up · Jun 18
334.05
Turned up · Jul 15
353.95
Turned up · Sep 16
374.46
Fundamentals
P/E
24.92
Fwd P/E
—
P/S
5.72
P/B
20.36
EV/EBITDA
17.29
ROE
89.3%
ROA
9.5%
Gross margin
74.3%
Net margin
—
Debt / equity
6.31
Rev growth
9.1%
EPS growth
5.5%
Earnings
next report after the closeNext report
Nov 2, 2026
EPS expected
5.90
Beat in last 4
4 of 4
2026-06-30reported 6.29 vs 5.73 expected+9.8%
2026-03-31reported 5.15 vs 4.85 expected+6.1%
2025-12-31reported 5.29 vs 4.83 expected+9.6%
2025-09-30reported 5.64 vs 5.11 expected+10.3%
Analyst coverage
43 analysts · as of 2026-09-01Strong buy
6
Buy
14
Hold
20
Sell
2
Strong sell
1
News
stories naming this company, last 21 daysEvery figure here is measured from live market data as of Oct 4, 05:45 PM. Nothing is estimated or filled in — where a figure shows — the source had no value for it, and a section you don’t see had no data at all. This describes what the market has already done. It is not a forecast, and not financial advice.